These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1697 related items for PubMed ID: 16786000

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W, Soejima H, Higashimoto K, Nakagawachi T, Urano T, Kudo S, Matsukura S, Matsuo S, Joh K, Mukai T.
    J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
    [Abstract] [Full Text] [Related]

  • 43. Transcriptional regulation of mouse delta-opioid receptor gene by CpG methylation: involvement of Sp3 and a methyl-CpG-binding protein, MBD2, in transcriptional repression of mouse delta-opioid receptor gene in Neuro2A cells.
    Wang G, Wei LN, Loh HH.
    J Biol Chem; 2003 Oct 17; 278(42):40550-6. PubMed ID: 12890683
    [Abstract] [Full Text] [Related]

  • 44. Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target.
    Ramachandran K, Gopisetty G, Gordian E, Navarro L, Hader C, Reis IM, Schulz WA, Singal R.
    Cancer Res; 2009 Feb 15; 69(4):1527-35. PubMed ID: 19190346
    [Abstract] [Full Text] [Related]

  • 45. Epigenetic and proteolytic inactivation of 14-3-3sigma in breast and prostate cancers.
    Horie-Inoue K, Inoue S.
    Semin Cancer Biol; 2006 Jun 15; 16(3):235-9. PubMed ID: 16682214
    [Abstract] [Full Text] [Related]

  • 46. Aberrant overexpression of an epithelial marker, 14-3-3sigma, in a subset of hematological malignancies.
    Motokura T, Nakamura Y, Sato H.
    BMC Cancer; 2007 Nov 25; 7():217. PubMed ID: 18036248
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells.
    Law AY, Lai KP, Ip CK, Wong AS, Wagner GF, Wong CK.
    Exp Cell Res; 2008 May 01; 314(8):1823-30. PubMed ID: 18394600
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Identification of differentially methylated CpG islands in prostate cancer.
    Yamada Y, Toyota M, Hirokawa Y, Suzuki H, Takagi A, Matsuzaki T, Sugimura Y, Yatani R, Shiraishi T, Watanabe M.
    Int J Cancer; 2004 Dec 10; 112(5):840-5. PubMed ID: 15386391
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
    Strathdee G, Davies BR, Vass JK, Siddiqui N, Brown R.
    Carcinogenesis; 2004 May 10; 25(5):693-701. PubMed ID: 14729589
    [Abstract] [Full Text] [Related]

  • 55. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
    Koizume S, Tachibana K, Sekiya T, Hirohashi S, Shiraishi M.
    Nucleic Acids Res; 2002 Nov 01; 30(21):4770-80. PubMed ID: 12409468
    [Abstract] [Full Text] [Related]

  • 56. Promoter Gene Methylation Regulates Clooxygenase-2 Expression in Androgen-Dependent and Independent Prostate Cancer Cells.
    Liu CY, Su SH, Chang TH, Hsieh ML, Chang YH, Pang JS, Chuang CK.
    World J Oncol; 2022 Jun 01; 13(3):107-116. PubMed ID: 35837323
    [Abstract] [Full Text] [Related]

  • 57. Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation.
    Akahira J, Sugihashi Y, Suzuki T, Ito K, Niikura H, Moriya T, Nitta M, Okamura H, Inoue S, Sasano H, Okamura K, Yaegashi N.
    Clin Cancer Res; 2004 Apr 15; 10(8):2687-93. PubMed ID: 15102672
    [Abstract] [Full Text] [Related]

  • 58. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
    Wischnewski F, Friese O, Pantel K, Schwarzenbach H.
    Mol Cancer Res; 2007 Jul 15; 5(7):749-59. PubMed ID: 17634428
    [Abstract] [Full Text] [Related]

  • 59. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
    Shao G, Berenguer J, Borczuk AC, Powell CA, Hei TK, Zhao Y.
    Cancer Res; 2006 May 01; 66(9):4566-73. PubMed ID: 16651406
    [Abstract] [Full Text] [Related]

  • 60. Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression.
    Gu P, Le Menuet D, Chung AC, Cooney AJ.
    Mol Cell Biol; 2006 Dec 01; 26(24):9471-83. PubMed ID: 17030610
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 85.